Ischemic Cerebral Stroke Market: Overview

Ischemic cerebral stroke occurs when blood vessels that supply blood to brain are blocked due to the formation of blood clots resulting in the corresponding loss of neurologic function. The symptoms of ischemic cerebral stroke complains include the abrupt onset of hemiparesis, quadriparesis and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia and decrease in the level of consciousness. 

Ischemic Cerebral Stroke Market: Segmentation

Ischemic cerebral stroke market can be segmented on the basis of the diagnostic techniques and treatments available. On the basis of the diagnostic techniques, ischemic cerebral stroke market is classifies into following segments:

  • Computed tomography (CT) angiography and CT scan
  • Carotid duplex scanning
  • Magnetic resonance imaging (MRI)
  • Digital subtraction angiography

CT scan is the most common technique, which is used for diagnosis of ischemic cerebral stroke, majorly due to its efficiency to capture the images in the form of axial slices or as volume studies in three-dimensional form. These three-dimensional images provide the doctor, better insight about the stroke condition. In addition to imaging diagnosis, doctors also perform lumbar puncture and other laboratory testing such as complete blood count, basic chemistry panel, coagulation studies and toxicology screening. These tests are performed to discover any additional disease condition which could hinder the treatment such as meningitis, coagulopathy and other concurrent illness such as diabetes, hypoglycemia, renal insufficiency and hyponatremia.

On the basis of the treatment, the ischemic cerebral stroke market is majorly classified into two classes namely medication treatment and surgical treatment. Surgical treatment involves the removal of the blood clots and fatty deposits from the artery in the neck. The surgery helps in reducing the risk of another stroke, but this method of treatment is not suitable for everyone. Therefore, medications capture the major share of the ischemic cerebral stroke treatment market. Drugs that are usually prescribed for treatment include:

  • Alteplase
  • Warfarin
  • Aspirin and Clopidrogel

Alteplase captures the major share of the ischemic cerebral stroke medication market followed by warfarin. Alteplase is used to break up blood clots and for restoring blood flow in the brain while warfarin prevents formation of blood clot. Aspirin and clopidrogel are prescribed to reduce the rate of formation of blood clots after a stroke. Moreover, many market players in ischemic cerebral stroke market are performing research for developing drugs that take less time for breaking blood clots and restoring blood flow. For instance, Stempeutics Research Pvt., Ltd. has developed a drug with the namely Stempeucel which is expected to show efficient results in the forecast period leading to the growth of ischemic cerebral stroke market. Currently, Stempeucel is under phase II clinical trials for treatment of ischemic cerebral stroke.

Ischemic Cerebral Stroke Market: region-wise Insight

North America leads the ischemic cerebral stroke market followed by Europe majorly due to high prevalence of ischemic cerebral stroke. According to the Centers for Disease Control and Prevention (CDC), stroke is a leading cause of death in U.S. and kills around 130,000 people every year and around 85% of the strokes are ischemic cerebral stroke. Such high prevalence of the disease leads to the increased need for diagnosis and treatment medications resulting in the growth of ischemic cerebral stroke market.

Asia-Pacific is growing rapidly in the ischemic cerebral stroke treatments market due to increasing prevalence of the disease and growing government support for spreading awareness about ischemic cerebral stroke. As for instance, in 2008, the Regional Comprehensive Stroke Center (CSC) program in South Korea was initiated by the Ministry of Health and Welfare of South Korea to spread awareness about the availability of treatments and to decrease the mortality rate of the stroke nationwide.

Ischemic Cerebral Stroke Market: Key Players

Other major players in the ischemic cerebral stroke market include Bayer AG, Boehringer Ingelheim GmbH, H. Lundbeck A/S, Bristol-Myers Squibb Company, ThromboGenics NV, Vernalis plc and Neurotec Pharma SL.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Ischemic Cerebral Stroke Market

Pre Book